Myomo (MYO) Income from Continuing Operations (2016 - 2025)
Myomo (MYO) posted Income from Continuing Operations of 3662915.0 for Q3 2025, up 20.92% on a QoQ basis from 4631972.0 in Q2 2025, and down 279.02% year-over-year from 2046055.23 in Q3 2024.
Myomo (MYO) Income from Continuing Operations (2016 - 2025) Analysis & Trends
Myomo's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 3662915.0 for Q3 2025.
- Quarterly Income from Continuing Operations fell 279.02% year-over-year to 3662915.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 5195255.0 (up 38.03% YoY) and the FY2024 annual result came in at 641042.0, up 107.87% from the prior year.
- Income from Continuing Operations was 3662915.0 for Q3 2025 at Myomo, up from 4631972.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 8664346.0 in Q4 2022 and bottomed at 4631972.0 in Q2 2025.
- A 5-year average of 1554106.53 and a median of 2644295.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 417.0% — and 2025, when it tumbled 312.98%.
- Myomo's Income from Continuing Operations stood at 2733198.0 in 2021, then surged by 417.0% to 8664346.0 in 2022, then sank by 128.39% to 2460105.0 in 2023, then jumped by 366.85% to 6564690.0 in 2024, then sank by 155.8% to 3662915.0 in 2025.
- Business Quant data shows MYO's Income from Continuing Operations at 3662915.0 in Q3 2025, 4631972.0 in Q2 2025, and 3465058.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.66 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | 6.56 Mn |
| Sep 30, 2024 | -966,409.00 |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Dec 31, 2023 | -2.46 Mn |
| Sep 30, 2023 | -2.03 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | 8.66 Mn |
| Sep 30, 2022 | -2.83 Mn |
| Jun 30, 2022 | -2.91 Mn |
| Mar 31, 2022 | -2.81 Mn |
| Dec 31, 2021 | -2.73 Mn |
| Sep 30, 2021 | -2.06 Mn |
| Jun 30, 2021 | -2.62 Mn |
| Mar 31, 2021 | -2.96 Mn |
| Dec 31, 2020 | -1.70 Mn |